Evolution of tobacco use indicators according to telephone surveys, 2006-2014

Deborah Carvalho Malta Sheila Rizzato Stopa Maria Aline Siqueira Santos Silvânia Suely Caribé de Araújo Andrade Tais Porto Oliveira Elier Broche Cristo Marta Maria Alves da Silva About the authors

Abstract:

The goal of this study was to describe the trend of tobacco-use indicators for adults in Brazilian state capitals. Simple linear regression was used to analyze tobacco-use trends according to data from telephone survey VIGITEL between 2006 and 2014. The prevalence of smokers in Brazil dropped 0.645p.p. per year this period, from 15.6% (2006) to 10.8% (2014). There was a decrease per sex, schooling, major regions, and in most age groups. The prevalence of former smokers dropped from 22.2% (2006) to 21.2% (2014); smoking 20 cigarettes or more per day went from 4.6% (2006) to 3% (2014). Passive smoking at home dropped 0.614p.p. per year since 2009, and was 9.4% in 2014. Passive smoking at the workplace decreased 0.54p.p. a year, reaching 8.9% in 2014. The prevalence trend of smokers is declining for sexes, schooling, and major regions in almost all age groups. This indicates that the global target of 30% reduction in tobacco use until 2025 is possible to be reached, reflecting the effectiveness of control actions for this risk factor in Brazil.

Keywords:
Smoking; Chronic Disease; Tobacco Smoke Pollution; Health Surveys; Epidemiological Surveillance

Introduction

The hazards of tobacco use are broadly documented in global and national studies 11. World Health Organization. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization; 2011.,22. Doll R, Hill AB. Smoking and carcinoma of the lung. Br Med J 1950; 2:739-58.,33. Almeida L, Szklo A, Sampaio M, Souza M, Martins LF, Szklo M, et al. Global Adult Tobacco Survey Data as a tool to monitor the WHO Framework Convention on Tobacco Control (WHO FCTC) implementation: the Brazilian case. Int J Environ Res Public Health 2012; 9:2520-36.. Tobacco is the main risk factor for chronic noncommunicable diseases (NCDs), which account for 63% of the deaths worldwide1, and 72% in Brazil 44. Schmidt MI, Duncan BB, Silva GA, Menezes AM, Monteiro CA, Barreto SM, et al. Chronic non-communicable diseases in Brazil: burden and current challenges. Lancet 2011; 377:1949-61.,55. Malta DC, Moura L, Prado RR, Escalante JC, Schmidt MI, Duncan BB. Mortalidade por doenças crônicas não transmissíveis no Brasil e suas regiões, 2000 a 2011. Epidemiol Serv Saúde 2014; 23:599-608..

Tobacco-related diseases include cancer (lung, oral, breast, others) chronic respiratory diseases, intrauterine growth restriction, predisposition to preterm delivery among others, in particular cardiovascular diseases 66. World Health Organization. WHO report on the Global Tobacco Epidemic 2013: enforcing bans on tobacco advertising, promotion and sponsorship. Geneva: World Health Organization; 2013.. In general, health hazards are due to both direct tobacco use and passive exposure to smoking 11. World Health Organization. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization; 2011.,22. Doll R, Hill AB. Smoking and carcinoma of the lung. Br Med J 1950; 2:739-58.,66. World Health Organization. WHO report on the Global Tobacco Epidemic 2013: enforcing bans on tobacco advertising, promotion and sponsorship. Geneva: World Health Organization; 2013.,77. World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization; 2009..

The World Health Organization (WHO) states that if no significant measure is taken globally, the tobacco-related deaths estimated for 2030 will reach 8 million, or 10% of the total global deaths 11. World Health Organization. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization; 2011.,66. World Health Organization. WHO report on the Global Tobacco Epidemic 2013: enforcing bans on tobacco advertising, promotion and sponsorship. Geneva: World Health Organization; 2013..

Currently, the prevalence of tobacco use worldwide is high, with significant variations among the different regions 88. Giovino GA, Mirza SA, Samet JM, Gupta PC, Jarvis MJ, Bhala N, et al. Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet 2012; 380:668-79.. In Brazil, the prevalence of smoking in 1989 was 34.8% in adults, and subsequent surveys evidenced significant reduction 99. Malta DC, Morais Neto OL, Silva Junior JB. Apresentação do plano de ações estratégicas para o enfrentamento das doenças crônicas não transmissíveis no Brasil, 2011 a 2022. Epidemiol Serv Saúde 2011; 20:425-38.,1010. Monteiro CA, Cavalcante TM, Moura EC, Claro RM, Szwarcwald CL. Population-based evidence of a strong decline in the prevalence of smokers in Brazil (1989-2003). Bull World Health Organ 2007; 85:527-34.. In 2013, the Brazilian National Health Survey (PNS in portuguese) indicated a prevalence of 14.7% regarding tobacco smoking 1111. Instituto Brasileiro de Geografia e Estatística. Pesquisa Nacional de Saúde: 2013. Percepção do estado de saúde, estilos de vida e doenças crônicas. Rio de Janeiro: Instituto Brasileiro de Geografia e Estatística; 2014..

The decrease of this indicator fulfills a commitment made by Brazil and WHO through their plans, launched respectively in 2011 and 2013, which are the Strategic Action Plan for Tackling Chronic Noncommunicable Diseases in Brazil, 2011 to 2022 99. Malta DC, Morais Neto OL, Silva Junior JB. Apresentação do plano de ações estratégicas para o enfrentamento das doenças crônicas não transmissíveis no Brasil, 2011 a 2022. Epidemiol Serv Saúde 2011; 20:425-38.,1212. Malta DC, Silva Júnior JB. O plano de ações estratégicas para o enfrentamento das doenças crônicas não transmissíveis no Brasil e a definição das metas globais para o enfrentamento dessas doenças até 2025: uma revisão. Epidemiol Serv Saúde 2013; 22:151-64., and the Global Action Plan for the Prevention and Control of NCDs1313. World Health Organization. WHO global action plan for the prevention and control of NCDs 2013-2020. Geneva: World Health Organization; 2013.; the latter having established the target of 30% reduction in tobacco-use prevalence worldwide between 2015 and 2025 1212. Malta DC, Silva Júnior JB. O plano de ações estratégicas para o enfrentamento das doenças crônicas não transmissíveis no Brasil e a definição das metas globais para o enfrentamento dessas doenças até 2025: uma revisão. Epidemiol Serv Saúde 2013; 22:151-64.. WHO has encouraged countries to monitor tobacco use as an essential measure to support control policies and reverse tobacco epidemic.

The monitoring of tobacco products is a commitment made by Brazil since 2005, when the Framework Convention on Tobacco Control (WHO-FCTC) was approved, to progressively deploy a national epidemiological surveillance system for tobacco use and other social, economic and health indicators. Therefore, the continuous monitoring of tobacco indicators is essential to support public policies 33. Almeida L, Szklo A, Sampaio M, Souza M, Martins LF, Szklo M, et al. Global Adult Tobacco Survey Data as a tool to monitor the WHO Framework Convention on Tobacco Control (WHO FCTC) implementation: the Brazilian case. Int J Environ Res Public Health 2012; 9:2520-36.. A good surveillance system should follow tobacco-use indicators, allowing the development of proper policies, measurement of impact effectiveness and, when necessary, the adjustment of the measures 1414. World Health Organization. MPOWER: a policy package to reverse the tobacco epidemic. Geneva: World Health Organization; 2008..

Thus, the Ministry of Health has established as a priority the organization of NCDs surveillance and the implementation of surveys, such as the Risk and Prospective Factors Surveillance System for Chronic Non-Communicable Diseases through Telephone Interview (VIGITEL) 1515. Departamento de Vigilância de Doenças e Agravos não Transmissíveis e Promoção da Saúde, Secretaria de Vigilância em Saúde, Ministério da Saúde. Vigitel Brasil 2015. Vigilância de Fatores de Risco e Proteção para Doenças Crônicas por Inquérito Telefônico: estimativas sobre frequência e distribuição sociodemográfica de de fatores de risco e proteção para doenças crônicas nas capitais dos 26 estados brasileiros e no Distrito Federal em 2015. Brasília: Ministério da Saúde; 2016., annually conducted since 2006 in the 26 Brazilian state capitals and the Federal District; and home-based surveys conducted every 5 years, such as the PNS 1111. Instituto Brasileiro de Geografia e Estatística. Pesquisa Nacional de Saúde: 2013. Percepção do estado de saúde, estilos de vida e doenças crônicas. Rio de Janeiro: Instituto Brasileiro de Geografia e Estatística; 2014. and the National Student Health every 3 years, among others 99. Malta DC, Morais Neto OL, Silva Junior JB. Apresentação do plano de ações estratégicas para o enfrentamento das doenças crônicas não transmissíveis no Brasil, 2011 a 2022. Epidemiol Serv Saúde 2011; 20:425-38..

The current study aims to describe the trends of tobacco-related indicators in Brazilian state capital cities and the Federal District between 2006 and 2014, collected by the telephone survey VIGITEL.

Methods

Information about risk factors and protection were analyzed based on VIGITEL survey information collected annually between 2006 and 2014, by means of telephone interviewing of the adult population (≥ 18 years old), living in the capital cities of the 26 Brazilian states and the Federal District.

VIGITEL uses probabilistic samples of adult population (≥ 18 years old) based on telephone landline records made available annually by the main home phone service providers in Brazil. Five thousand telephone landlines of each city were drawn, which are divided in replicated subsamples of 200 lines each, for identification of the eligible lines, i.e., active residential lines. After line eligibility is confirmed, the resident to be interviewed is selected 1515. Departamento de Vigilância de Doenças e Agravos não Transmissíveis e Promoção da Saúde, Secretaria de Vigilância em Saúde, Ministério da Saúde. Vigitel Brasil 2015. Vigilância de Fatores de Risco e Proteção para Doenças Crônicas por Inquérito Telefônico: estimativas sobre frequência e distribuição sociodemográfica de de fatores de risco e proteção para doenças crônicas nas capitais dos 26 estados brasileiros e no Distrito Federal em 2015. Brasília: Ministério da Saúde; 2016..

Post-stratification weights were attributed for one to obtain reliable estimates of the adult population with a landline in each city, considering the following variables: sex (female and male), age group (18-24, 25-34, 35-44, 45-54, 55-64 and 65 and older), and schooling (no schooling, incomplete basic education, complete basic education, incomplete high school education, complete high school education, incomplete higher education, complete higher education). Further methodological details are shown in other publications 1515. Departamento de Vigilância de Doenças e Agravos não Transmissíveis e Promoção da Saúde, Secretaria de Vigilância em Saúde, Ministério da Saúde. Vigitel Brasil 2015. Vigilância de Fatores de Risco e Proteção para Doenças Crônicas por Inquérito Telefônico: estimativas sobre frequência e distribuição sociodemográfica de de fatores de risco e proteção para doenças crônicas nas capitais dos 26 estados brasileiros e no Distrito Federal em 2015. Brasília: Ministério da Saúde; 2016.,1616. Bernal R. Inquéritos por telefone: inferências válidas em regiões com baixa taxa de cobertura de linhas residenciais [Tese de Doutorado]. São Paulo: Faculdade de Saúde Pública, Universidade de São Paulo; 2011..

Starting in 2012, the post-stratification weight of each subject of the VIGITEL sample was calculated with the rake method 1616. Bernal R. Inquéritos por telefone: inferências válidas em regiões com baixa taxa de cobertura de linhas residenciais [Tese de Doutorado]. São Paulo: Faculdade de Saúde Pública, Universidade de São Paulo; 2011.,1717. Izrael D, Hoaglin DC, Battaglia MP. A SAS macro for balancing a weighted sample. In: Proceedings of the Twenty-Fifth Annual SAS Users Group International Conference. Cary: SAS Institute; 2000. p. 207-29., using the SAS (SAS Inst., Cary, USA) application specific routine 1717. Izrael D, Hoaglin DC, Battaglia MP. A SAS macro for balancing a weighted sample. In: Proceedings of the Twenty-Fifth Annual SAS Users Group International Conference. Cary: SAS Institute; 2000. p. 207-29.. This method uses iterative procedures that take into account successive comparisons between the distribution estimates of each sociodemographic variable of the VIGITEL sample and the total city population. These comparisons culminate in finding the weights that, once applied to the VIGITEL sample, make the sociodemographic distribution of the variables equal to the estimated distribution for the total city population.

The VIGITEL questionnaire has some 90 questions on issues related to the demographic and socioeconomic characteristics of the subjects; their diet and physical activity standards; cigarette smoking and alcohol consumption, among others.

In the current study, temporal trend analyses were performed between 2006 and 2014 for tobacco-related indicators: (1) smokers: the person who gave a positive answer to the question “Do you smoke?” was considered a smoker, regardless of the number of cigarettes, frequency and duration of the smoking habit; (2) former smokers: the person who gave a positive answer to the question “Have you ever smoked?”, regardless of the number of cigarettes and duration of the smoking habit; (3) Proportion of smokers who smoke 20 or more cigarettes a day: number of people who smoke 20 or more cigarettes a day according to their answer to the question: “How many cigarettes do you smoke a day?”; starting in 2009 questions about passive smoking were included. This is why the trend presented here about these two indicators relates to the period of 2009 to 2014: (4) Proportion of passive smokers at home: number of non-smoking individuals who reported that at least one of the persons he/she lived with smoked at home, in response to the question: “Do any of the people with whom you live smoke at home?”; (5) Proportion of passive smokers at the workplace: number of non-smoking individuals who reported that at least one person smoked in the workplace, in response to the question: “Does any co-worker smoke in the same environment you work in?”. The denominator of all investigated indicators is the total of individuals interviewed.

The temporal trend analysis of tobacco-use indicators was stratified according to sex, age, schooling and region of the country. The method used to estimate the trend was the simple linear regression model, whose response variable (Yi) is the proportion of the indicator, and the explanatory variable (Xi) is time (year of the assessment). A negative model-adjusted line angular coefficient (β) shows that the relationship between the indicator and the time is decreasing; otherwise, the relationship is increasing. The positive value of the angular coefficient represents the average annual increase in proportion of the indicator for each time unit; otherwise, it shows that the average annual proportion has dropped.

The proportions for the 2006 to 2014 period were presented, as well as the trend expressed by the angular coefficient of the line and the trend significance level. Model adequacy measures were used, analysis of residuals with 5% significance level. For data processing and statistical analysis, the software Stata version 11.1 (StataCorp LP, College Station, USA). The proportion estimation commands were employed taking into account the weighting factors of each subject interviewed by the VIGITEL survey 1515. Departamento de Vigilância de Doenças e Agravos não Transmissíveis e Promoção da Saúde, Secretaria de Vigilância em Saúde, Ministério da Saúde. Vigitel Brasil 2015. Vigilância de Fatores de Risco e Proteção para Doenças Crônicas por Inquérito Telefônico: estimativas sobre frequência e distribuição sociodemográfica de de fatores de risco e proteção para doenças crônicas nas capitais dos 26 estados brasileiros e no Distrito Federal em 2015. Brasília: Ministério da Saúde; 2016..

This study was approved by the National Ethics Research Committee with Humans (Conep), opinion n. 355.590. The signing of the free consent form was replaced by verbal consent at the time of the telephone contacts with the interviewees.

Results

In this study, differences were found in tobacco-use prevalence according to sex, age, schooling, and region. Over the period of time investigated, higher prevalences were presented by males, less schooled individuals, age group between 45 and 54 years of age, and residents in the Southern region of Brazil.

In the trend analysis, the prevalence of smokers in Brazil presented a relative reduction of 0.645p.p. per survey year, ranging from 15.6% in 2006 to 10.8% in 2014. For males, the decrease between 2006 and 2014, was at an average rate of 0.793p.p. a year, from 19.3% (2006) to 12.8% (2014); for females the reduction was 0.518p.p. a year, from 12.4% (2006) to 9% (2014) (Table 1). The proportion of smokers also decreased significantly in some age groups, with the highest reduction in the 45-54 age group, having reached 1.082p.p. a year; the lowest reduction was among individuals 65 years and older (-0.213p.p. a year) (Table 1).

Table 1
Trends in the proportion of smokers, per sex, age group, education, Brazil and regions. VIGITEL 2006-2014.

There was also reduction among all education levels. The rate of smokers with more schooling dropped from 10.9% in 2006 to 6.8% in 2014, and among adults with up to 8 years of schooling the smoking prevalence also decreased, even though the figures are higher, dropping from 19.1% (2006) to 14.1% (2014). Significant reductions were also seen in all regions of the country (Table 1).

The total population of former smokers dropped from 22.2% to 21.2%; in males, the proportion of former smokers went from 26.7% to 25.6%. In addition, there was an increase in the proportion of former smokers of the age group 55 to 64 years, and among individuals with 0 to 8 years of schooling, from 27.9% to 30.2%. A decrease in the population of former smokers was also seen in the Northeast Region (Table 2).

Table 2
Trends in the proportion of former smoker, per sex, age group, education, Brazil and regions. VIGITEL 2006-2014.

The prevalence of adults who state smoking 20 cigarettes or more a day decreased from 4.6% (2006) to 3% (2014), a reduction of 0.195p.p. a year. The decrease was observed in both sexes, but it was steeper among males. A decrease was also seen in the age groups 18 to 24 years and 35 to 54 years. Furthermore, significant reduction was observed in all regions of the country and among the population with 0 to 8 years of schooling, and 12 years of schooling or more (Table 3).

Table 3
Trends in the proportion of smokers who smoke 20 cigarettes or more a day, per sex, age group, education, Brazil and regions. VIGITEL 2006-2014.

Regarding passive smoking at home, a significant reduction in all sex and schooling categories was seen. This reduction was higher in females, from 13.4% (2009) to 10% (2014), and for individuals with 0 to 8 years of schooling, dropping from 12.7% (2009) to 9% (2014). A significant decrease was also found in all investigated age groups, except in individuals 35 to 44 years. Passive smoking at home was also significantly reduced in regions North, Northeast and Southeast (Table 4).

Table 4
Trends in the proportion of passive smoking at home, per sex, age group, education, Brazil and regions. VIGITEL 2006-2014.

Passive smoke at the workplace dropped from 12.1% (2009) to 8.9% (2014), and remained higher among males throughout the period. In regards to age groups, a reduction was seen in individuals between the ages of 25 and 54 years. A decrease was also seen in all but the Central region. A reduction of passive smoking at the workplace was also seen among individuals with 0 to 11 years of schooling (Table 5).

Table 5
Trends in the proportion of passive smoking at the workplace, per sex, age group, education, Brazil and regions. VIGITEL 2006-2014.

Discussion

Brazil has made progress in regards to its commitment to national 99. Malta DC, Morais Neto OL, Silva Junior JB. Apresentação do plano de ações estratégicas para o enfrentamento das doenças crônicas não transmissíveis no Brasil, 2011 a 2022. Epidemiol Serv Saúde 2011; 20:425-38. and global 1313. World Health Organization. WHO global action plan for the prevention and control of NCDs 2013-2020. Geneva: World Health Organization; 2013. tobacco-use reduction goals. The results presented here indicate significant improvement in tobacco-use indicators in the country, and the advances are seen in practically all sexes, years of schooling, age, and region, reflecting the importance of the VIGITEL survey in the annual monitoring of tobacco indicators 1515. Departamento de Vigilância de Doenças e Agravos não Transmissíveis e Promoção da Saúde, Secretaria de Vigilância em Saúde, Ministério da Saúde. Vigitel Brasil 2015. Vigilância de Fatores de Risco e Proteção para Doenças Crônicas por Inquérito Telefônico: estimativas sobre frequência e distribuição sociodemográfica de de fatores de risco e proteção para doenças crônicas nas capitais dos 26 estados brasileiros e no Distrito Federal em 2015. Brasília: Ministério da Saúde; 2016..

In Brazil, population studies with adults on tobacco use begun in 1989 with the Brazilian National Health and Nutrition Survey (PNSN in portuguese), which showed a prevalence of 34.8% 1010. Monteiro CA, Cavalcante TM, Moura EC, Claro RM, Szwarcwald CL. Population-based evidence of a strong decline in the prevalence of smokers in Brazil (1989-2003). Bull World Health Organ 2007; 85:527-34.. In 2003, The World Health Survey evidenced significant reduction of tobacco-use, with the prevalence dropping to 22.4% 1010. Monteiro CA, Cavalcante TM, Moura EC, Claro RM, Szwarcwald CL. Population-based evidence of a strong decline in the prevalence of smokers in Brazil (1989-2003). Bull World Health Organ 2007; 85:527-34.; then, in 2008 the National Tobacco Survey (PETab) 1818. Instituto Nacional de Câncer; Organização Pan-Americana da Saúde. Pesquisa Especial de Tabagismo (PETab): relatório Brasil. Rio de Janeiro: Instituto Nacional de Câncer; 2011. showed the rate of 17.2% and, in 2013, the National Health Survey found 14.7% 1111. Instituto Brasileiro de Geografia e Estatística. Pesquisa Nacional de Saúde: 2013. Percepção do estado de saúde, estilos de vida e doenças crônicas. Rio de Janeiro: Instituto Brasileiro de Geografia e Estatística; 2014..

There are important differences in regards to gender, with men typically smoking more than women. The highest prevalence of tobacco use among women is in Europe (20%) 66. World Health Organization. WHO report on the Global Tobacco Epidemic 2013: enforcing bans on tobacco advertising, promotion and sponsorship. Geneva: World Health Organization; 2013., followed by the Americas, where men smoke about 1.5 times more than women 66. World Health Organization. WHO report on the Global Tobacco Epidemic 2013: enforcing bans on tobacco advertising, promotion and sponsorship. Geneva: World Health Organization; 2013.. In the Western Pacific Region, the prevalences among men are quite high, about 46%, and low among women 66. World Health Organization. WHO report on the Global Tobacco Epidemic 2013: enforcing bans on tobacco advertising, promotion and sponsorship. Geneva: World Health Organization; 2013.. Similarly in Southeast Asia, men smoke up to 10 times more than women 88. Giovino GA, Mirza SA, Samet JM, Gupta PC, Jarvis MJ, Bhala N, et al. Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet 2012; 380:668-79.. Also in the countries of the Global Adults Tobacco Survey the frequencies tend to be lower among women. In countries such as Egypt, India and Bangladesh, with strong religious and cultural influences, the prevalences in women are quite low, under 2%, compared to about 30% among men 88. Giovino GA, Mirza SA, Samet JM, Gupta PC, Jarvis MJ, Bhala N, et al. Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet 2012; 380:668-79..

The power of tobacco among men has historical, cultural and market explanations. Since the beginning of the 20th century the tobacco industry tried to associate the idea of strength, virility and power in its tobacco advertisements 1919. Amos A, Haglund M. From social taboo to "torch of freedom": the marketing of cigarettes to women. Tob Control 2000; 9:3-8.,2020. Apelberg B, Aghi M, Asma S, Donaldson E, Yeong CC, Vaithinathan R. Prevalence of tobacco use and factors influencing initiation and maintenance among women. In: Samet JM, Soon-Young Y, editors. Gender, women, and the tobacco epidemic. Geneva: World Health Organization; 2010. p. 29-50.. In most countries this was a protective factor for women, who started the habit later. In the Western world, this initiation was fostered by the tobacco industry in disseminating that it favored gender equality, and to strengthen female emancipation and self-affirmation 2020. Apelberg B, Aghi M, Asma S, Donaldson E, Yeong CC, Vaithinathan R. Prevalence of tobacco use and factors influencing initiation and maintenance among women. In: Samet JM, Soon-Young Y, editors. Gender, women, and the tobacco epidemic. Geneva: World Health Organization; 2010. p. 29-50.,2121. Huxley R, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet 2011; 378:1297-300.,2222. Vollset SE, Tverdal A, Gjessing HK. Smoking and deaths between 40 and 70 years of age in women and men. Ann Intern Med 2006; 144:381-9.. In Brazil this movement was stronger in the 1960s and 1970s, and broadly stimulated by the movie industry 33. Almeida L, Szklo A, Sampaio M, Souza M, Martins LF, Szklo M, et al. Global Adult Tobacco Survey Data as a tool to monitor the WHO Framework Convention on Tobacco Control (WHO FCTC) implementation: the Brazilian case. Int J Environ Res Public Health 2012; 9:2520-36.,2323. Malta DC, Iser BPM, Sá NNB, Yokota RTC, Moura L, Claro RM, et al. Trends in tobacco consumption from 2006 to 2011 in Brazilian capitals according to the VIGITEL survey. Cad Saúde Pública 2013; 29:812-22..

A reduction in prevalence of smoking and in the use of heavier tobacco products was seen in both sexes, in all regions. The literature indicates that low income and schooling are associated with higher tobacco-use prevalences in Brazil 33. Almeida L, Szklo A, Sampaio M, Souza M, Martins LF, Szklo M, et al. Global Adult Tobacco Survey Data as a tool to monitor the WHO Framework Convention on Tobacco Control (WHO FCTC) implementation: the Brazilian case. Int J Environ Res Public Health 2012; 9:2520-36.,2323. Malta DC, Iser BPM, Sá NNB, Yokota RTC, Moura L, Claro RM, et al. Trends in tobacco consumption from 2006 to 2011 in Brazilian capitals according to the VIGITEL survey. Cad Saúde Pública 2013; 29:812-22. and in other countries 88. Giovino GA, Mirza SA, Samet JM, Gupta PC, Jarvis MJ, Bhala N, et al. Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet 2012; 380:668-79..

Another important trend was reduction of smoking and use of heavier tobacco products among all schooling levels, being steeper in less schooled populations. This is a very positive factor, as tobacco use is higher among low schooling and income populations, which worsens health inequalities and predisposes the most vulnerable population to higher NCDs prevalence 11. World Health Organization. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization; 2011.. Expenditures with smoking impose an economic burden on the low-income population 1818. Instituto Nacional de Câncer; Organização Pan-Americana da Saúde. Pesquisa Especial de Tabagismo (PETab): relatório Brasil. Rio de Janeiro: Instituto Nacional de Câncer; 2011. due to the costs of the addiction and health expenses; therefore it is important to advance further in reducing prevalence in this population.

All regions showed a tendency of decrease in practically all indicators, with the highest reductions in the Northern and Northeastern regions. Higher prevalences of smoking and use of heavier tobacco products are seen in the Southern and Southeastern regions. The lower prevalences in the Northern and Northeastern regions are explained by cultural issues, weak presence of the tobacco industry, and lower prevalence among women, considering that historically their initiation in these regions has always been lower 2424. Malta DC, Moura EC, Silva SA, Oliveira PPV, Costa e Silva VL. Prevalência do tabagismo em adultos residentes nas capitais dos estados e no Distrito Federal, Brasil, 2008. J Bras Pneumol 2010; 36:75-83.. Concurrently, the Southern region presents the higher prevalences due to the agricultural production in the area, the presence of tobacco manufacturers 2525. World Health Organization; International Agency Research Cancer. GLOBOCAN 2012: Estimated Incidence, Mortality and Prevalence Worldwide in 2012. Geneva: World Health Organization/Lyon: International Agency Research Cancer; 2012., and cultural characteristics such as the influence of migrant populations in the past, and frequent contact with populations that live in the border area of neighboring countries, where tobacco-use prevalence is high 1818. Instituto Nacional de Câncer; Organização Pan-Americana da Saúde. Pesquisa Especial de Tabagismo (PETab): relatório Brasil. Rio de Janeiro: Instituto Nacional de Câncer; 2011.,2626. Vargas MA, Oliveira BF. Estratégias de diversificação em áreas de cultivo de tabaco no Vale do Rio Pardo: uma análise comparativa. Revista de Economia e Sociologia Rural 2012; 50:157-74..

VIGITEL showed a reduction of passive smoking at home and at the workplace for both sexes, for most age groups, schooling levels and regions. The Central Region did not present a reduction of these indicators, and the Southern region remained stable in regards to passive smoking at home. Passive smoking subjects non-smokers to the same risks and diseases caused by direct smoking, except for the magnitude; while smoking may increase the risk of death 20 to 30 times, passive smoking increases this risk 30 to 50% 2525. World Health Organization; International Agency Research Cancer. GLOBOCAN 2012: Estimated Incidence, Mortality and Prevalence Worldwide in 2012. Geneva: World Health Organization/Lyon: International Agency Research Cancer; 2012.,2727. Zamboni M. Epidemiologia do câncer do pulmão. J Pneumol 2002; 2841-7..

Data from the PNS rated passive smoking at the workplace in 13.5%, and at home in 10.7%. With the decree that forbids smoking in collective environments, passive smoking at the workplace is expected to reduce even further 1111. Instituto Brasileiro de Geografia e Estatística. Pesquisa Nacional de Saúde: 2013. Percepção do estado de saúde, estilos de vida e doenças crônicas. Rio de Janeiro: Instituto Brasileiro de Geografia e Estatística; 2014..

Compared with other countries, Brazil has the lowest prevalences, as ascertained in a comparative study conducted by the WHO and partners in 2012 88. Giovino GA, Mirza SA, Samet JM, Gupta PC, Jarvis MJ, Bhala N, et al. Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet 2012; 380:668-79.. This study showed that among 16 countries (China, Russia, Thailand, Bangladesh, Egypt, India, Mexico, Philippines, Poland, Turkey, Ukraine, Vietnam, others) where a great part of the world population lived, over 3 billion people, Brazil had the lowest tobacco-use prevalence 88. Giovino GA, Mirza SA, Samet JM, Gupta PC, Jarvis MJ, Bhala N, et al. Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet 2012; 380:668-79..

As in the current study, a drop in tobacco use has also been observed in other countries, such as the United States, Uruguay, Argentina, European countries and others, even though the figures are still high worldwide, which indicates there is much yet to be done. The highest prevalences are found in Europe, reaching around 30%, and the lowest, in Africa 66. World Health Organization. WHO report on the Global Tobacco Epidemic 2013: enforcing bans on tobacco advertising, promotion and sponsorship. Geneva: World Health Organization; 2013..

A limiting factor of the methodology used by the VIGITEL survey lies in the fact that the study is done with adults living in state capital cities and the Federal District who have a landline at home, which limits the representativeness of the sample. This problem is minimized by the use of weighting factors, which try to match the demographic characteristics of the Vigitel sample to those of the general adult population, according to the Brazilian Institute of Geography and Statistics (IBGE) census data. Starting in 2012, all prevalences found by the VIGITEL survey were revised according to the use of the post-stratification rake methodology and the updated annual population estimates from census projections. Therefore, the trend analyses presented in this study were recalculated, and may differ from previously published data 2323. Malta DC, Iser BPM, Sá NNB, Yokota RTC, Moura L, Claro RM, et al. Trends in tobacco consumption from 2006 to 2011 in Brazilian capitals according to the VIGITEL survey. Cad Saúde Pública 2013; 29:812-22..

The monitoring of tobacco indicators in the countries is an actual need, in dealing with the reduction goals established by the WHO Global Action Plan for the Prevention and Control of NCDs 1313. World Health Organization. WHO global action plan for the prevention and control of NCDs 2013-2020. Geneva: World Health Organization; 2013.. However, more than 100 countries worldwide do not have monitoring initiatives, making it hard to accurately compare and monitor tobacco-use trends 1414. World Health Organization. MPOWER: a policy package to reverse the tobacco epidemic. Geneva: World Health Organization; 2008.. Brazil has been considered an example for the world in terms of tobacco monitoring, and in 2015 received an award from the Bloomberg Foundation for its initiatives in the organization of tobacco monitoring and surveillance in the country 2828. Bloomberg Philanthropies. Bloomberg Philanthropies Awards for Global Tobacco Control: Meet the winning organizations. http://www.bloomberg.org/blog/2015-bloomberg-philanthropies-awards-global-tobacco-control-meet-winning-organizations/ (acessado em 10/Jun/2015).
http://www.bloomberg.org/blog/2015-bloom...
.

Brazil has also been internationally acknowledged for its actions in the fields of regulation, education, prevention and governance 88. Giovino GA, Mirza SA, Samet JM, Gupta PC, Jarvis MJ, Bhala N, et al. Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet 2012; 380:668-79.,2828. Bloomberg Philanthropies. Bloomberg Philanthropies Awards for Global Tobacco Control: Meet the winning organizations. http://www.bloomberg.org/blog/2015-bloomberg-philanthropies-awards-global-tobacco-control-meet-winning-organizations/ (acessado em 10/Jun/2015).
http://www.bloomberg.org/blog/2015-bloom...
. The regulatory measures adopted comply with the cost-effective interventions published by the WHO for the prevention of NCDs 11. World Health Organization. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization; 2011., such as: (a) raising taxes and prices on tobacco products; (b) prohibition to smoke in public places; (c) the inclusion of tobacco-use hazard warnings; (d) prohibition of tobacco advertisement, sponsorship and promotion1. Among recent regulatory measures, mention should be made of Law 12,546/2011, smoke-free environments, and its regulation by Presidential Decree 8.262/2014, which banned smoking in closed environments, regulated cigarette exhibition in the points of sale only and expanded the printing space for public health warnings 1515. Departamento de Vigilância de Doenças e Agravos não Transmissíveis e Promoção da Saúde, Secretaria de Vigilância em Saúde, Ministério da Saúde. Vigitel Brasil 2015. Vigilância de Fatores de Risco e Proteção para Doenças Crônicas por Inquérito Telefônico: estimativas sobre frequência e distribuição sociodemográfica de de fatores de risco e proteção para doenças crônicas nas capitais dos 26 estados brasileiros e no Distrito Federal em 2015. Brasília: Ministério da Saúde; 2016.. Other measures increased cigarette taxation to 85%, and established minimum prices for tobacco in accordance with the best evidences for reduction of tobacco use. Another milestone that improved actions governance was Brazil signing the WHO-FCTC, in 2005 66. World Health Organization. WHO report on the Global Tobacco Epidemic 2013: enforcing bans on tobacco advertising, promotion and sponsorship. Geneva: World Health Organization; 2013.,2929. Azevedo-Silva G, Valente JG, Malta DC. Tendências do tabagismo na população adulta das capitais brasileiras: uma análise dos dados de inquéritos telefônicos de 2006 a 2009. Rev Bras Epidemiol 2011; 14 Suppl 1:103-14..

Further advances in this field are necessary, like revisiting the issues on additives, which was regulated by the Collegiate Board Resolution (RDC) 14/2012 of the Brazilian Health Regulatory Agency (Anvisa). This regulation banned the use of cigarette additives, which give cigarettes a sugary flavor or pleasant scents, making them a more palatable product, targeting younger people to initiate the habit of smoking 3030. Agência Nacional de Vigilância Sanitária. Resolução - RDC Nº 14, de 15 de março de 2012. Dispõe sobre os limites máximos de alcatrão, nicotina e monóxido de carbono nos cigarros e a restrição do uso de aditivos nos produtos fumígenos derivados do tabaco, e dá outras providências. http://portal.anvisa.gov.br/wps/wcm/connect/d50d8f804d44b146bcecfe4031a95fac/Resolucao_RDC_14_Teores_e_Aditivos_16Mar12.pdf?MOD=AJPERES (acessado em 10/Jun/2015).
http://portal.anvisa.gov.br/wps/wcm/conn...
. This measure, however, was questioned by the tobacco industry in 2013, and the Brazilian Supreme Court gave a temporary injunction suspending the effect of the regulation. Another global discussion, led by Australia, is for the adoption of generic cigarette packs, with no logos or promotional texts. It is important that Brazil adopt this type of packs to protect adolescents and younger people. These and other measures are necessary in the continuing process of fighting tobacco use.

Conclusion

This study shows an improvement of all tobacco-related indicators in Brazil over the investigated period. There was a reduction in the prevalence of smokers according to sex, age, schooling and in all regions of the country. There was also a decrease in the proportion of heavy smokers, who smoked 20 cigarettes or more daily, according to sex, age, schooling and regions. A decrease in passive smoking at home according to sex, age, schooling, and in the Northern, Northeastern and Southeastern regions. A decrease in passive smoking at the workplace according to sex, age, schooling and in all but the Central Region. An increase of former smokers was seen for the age groups 55 to 64 years, 65 years and older, and for less educated individuals.

A decrease in prevalences analyzed in this paper ascertain the ongoing decline of smoking in Brazil, and indicate that the reduction goals established by the national and global Plans for Tackling NCDs are likely to be met, or even surpassed.

Acknowledgments

The Health Surveillance Secretariat, Ministry of Health, Brasília, Brazil. The National Council for Scientific and Technological Development for the research grant given to DC Malta.

References

  • 1
    World Health Organization. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization; 2011.
  • 2
    Doll R, Hill AB. Smoking and carcinoma of the lung. Br Med J 1950; 2:739-58.
  • 3
    Almeida L, Szklo A, Sampaio M, Souza M, Martins LF, Szklo M, et al. Global Adult Tobacco Survey Data as a tool to monitor the WHO Framework Convention on Tobacco Control (WHO FCTC) implementation: the Brazilian case. Int J Environ Res Public Health 2012; 9:2520-36.
  • 4
    Schmidt MI, Duncan BB, Silva GA, Menezes AM, Monteiro CA, Barreto SM, et al. Chronic non-communicable diseases in Brazil: burden and current challenges. Lancet 2011; 377:1949-61.
  • 5
    Malta DC, Moura L, Prado RR, Escalante JC, Schmidt MI, Duncan BB. Mortalidade por doenças crônicas não transmissíveis no Brasil e suas regiões, 2000 a 2011. Epidemiol Serv Saúde 2014; 23:599-608.
  • 6
    World Health Organization. WHO report on the Global Tobacco Epidemic 2013: enforcing bans on tobacco advertising, promotion and sponsorship. Geneva: World Health Organization; 2013.
  • 7
    World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization; 2009.
  • 8
    Giovino GA, Mirza SA, Samet JM, Gupta PC, Jarvis MJ, Bhala N, et al. Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet 2012; 380:668-79.
  • 9
    Malta DC, Morais Neto OL, Silva Junior JB. Apresentação do plano de ações estratégicas para o enfrentamento das doenças crônicas não transmissíveis no Brasil, 2011 a 2022. Epidemiol Serv Saúde 2011; 20:425-38.
  • 10
    Monteiro CA, Cavalcante TM, Moura EC, Claro RM, Szwarcwald CL. Population-based evidence of a strong decline in the prevalence of smokers in Brazil (1989-2003). Bull World Health Organ 2007; 85:527-34.
  • 11
    Instituto Brasileiro de Geografia e Estatística. Pesquisa Nacional de Saúde: 2013. Percepção do estado de saúde, estilos de vida e doenças crônicas. Rio de Janeiro: Instituto Brasileiro de Geografia e Estatística; 2014.
  • 12
    Malta DC, Silva Júnior JB. O plano de ações estratégicas para o enfrentamento das doenças crônicas não transmissíveis no Brasil e a definição das metas globais para o enfrentamento dessas doenças até 2025: uma revisão. Epidemiol Serv Saúde 2013; 22:151-64.
  • 13
    World Health Organization. WHO global action plan for the prevention and control of NCDs 2013-2020. Geneva: World Health Organization; 2013.
  • 14
    World Health Organization. MPOWER: a policy package to reverse the tobacco epidemic. Geneva: World Health Organization; 2008.
  • 15
    Departamento de Vigilância de Doenças e Agravos não Transmissíveis e Promoção da Saúde, Secretaria de Vigilância em Saúde, Ministério da Saúde. Vigitel Brasil 2015. Vigilância de Fatores de Risco e Proteção para Doenças Crônicas por Inquérito Telefônico: estimativas sobre frequência e distribuição sociodemográfica de de fatores de risco e proteção para doenças crônicas nas capitais dos 26 estados brasileiros e no Distrito Federal em 2015. Brasília: Ministério da Saúde; 2016.
  • 16
    Bernal R. Inquéritos por telefone: inferências válidas em regiões com baixa taxa de cobertura de linhas residenciais [Tese de Doutorado]. São Paulo: Faculdade de Saúde Pública, Universidade de São Paulo; 2011.
  • 17
    Izrael D, Hoaglin DC, Battaglia MP. A SAS macro for balancing a weighted sample. In: Proceedings of the Twenty-Fifth Annual SAS Users Group International Conference. Cary: SAS Institute; 2000. p. 207-29.
  • 18
    Instituto Nacional de Câncer; Organização Pan-Americana da Saúde. Pesquisa Especial de Tabagismo (PETab): relatório Brasil. Rio de Janeiro: Instituto Nacional de Câncer; 2011.
  • 19
    Amos A, Haglund M. From social taboo to "torch of freedom": the marketing of cigarettes to women. Tob Control 2000; 9:3-8.
  • 20
    Apelberg B, Aghi M, Asma S, Donaldson E, Yeong CC, Vaithinathan R. Prevalence of tobacco use and factors influencing initiation and maintenance among women. In: Samet JM, Soon-Young Y, editors. Gender, women, and the tobacco epidemic. Geneva: World Health Organization; 2010. p. 29-50.
  • 21
    Huxley R, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet 2011; 378:1297-300.
  • 22
    Vollset SE, Tverdal A, Gjessing HK. Smoking and deaths between 40 and 70 years of age in women and men. Ann Intern Med 2006; 144:381-9.
  • 23
    Malta DC, Iser BPM, Sá NNB, Yokota RTC, Moura L, Claro RM, et al. Trends in tobacco consumption from 2006 to 2011 in Brazilian capitals according to the VIGITEL survey. Cad Saúde Pública 2013; 29:812-22.
  • 24
    Malta DC, Moura EC, Silva SA, Oliveira PPV, Costa e Silva VL. Prevalência do tabagismo em adultos residentes nas capitais dos estados e no Distrito Federal, Brasil, 2008. J Bras Pneumol 2010; 36:75-83.
  • 25
    World Health Organization; International Agency Research Cancer. GLOBOCAN 2012: Estimated Incidence, Mortality and Prevalence Worldwide in 2012. Geneva: World Health Organization/Lyon: International Agency Research Cancer; 2012.
  • 26
    Vargas MA, Oliveira BF. Estratégias de diversificação em áreas de cultivo de tabaco no Vale do Rio Pardo: uma análise comparativa. Revista de Economia e Sociologia Rural 2012; 50:157-74.
  • 27
    Zamboni M. Epidemiologia do câncer do pulmão. J Pneumol 2002; 2841-7.
  • 28
    Bloomberg Philanthropies. Bloomberg Philanthropies Awards for Global Tobacco Control: Meet the winning organizations. http://www.bloomberg.org/blog/2015-bloomberg-philanthropies-awards-global-tobacco-control-meet-winning-organizations/ (acessado em 10/Jun/2015).
    » http://www.bloomberg.org/blog/2015-bloomberg-philanthropies-awards-global-tobacco-control-meet-winning-organizations/
  • 29
    Azevedo-Silva G, Valente JG, Malta DC. Tendências do tabagismo na população adulta das capitais brasileiras: uma análise dos dados de inquéritos telefônicos de 2006 a 2009. Rev Bras Epidemiol 2011; 14 Suppl 1:103-14.
  • 30
    Agência Nacional de Vigilância Sanitária. Resolução - RDC Nº 14, de 15 de março de 2012. Dispõe sobre os limites máximos de alcatrão, nicotina e monóxido de carbono nos cigarros e a restrição do uso de aditivos nos produtos fumígenos derivados do tabaco, e dá outras providências. http://portal.anvisa.gov.br/wps/wcm/connect/d50d8f804d44b146bcecfe4031a95fac/Resolucao_RDC_14_Teores_e_Aditivos_16Mar12.pdf?MOD=AJPERES (acessado em 10/Jun/2015).
    » http://portal.anvisa.gov.br/wps/wcm/connect/d50d8f804d44b146bcecfe4031a95fac/Resolucao_RDC_14_Teores_e_Aditivos_16Mar12.pdf?MOD=AJPERES

Publication Dates

  • Publication in this collection
    21 Sept 2017

History

  • Received
    25 Aug 2015
  • Reviewed
    08 Apr 2016
  • Accepted
    02 May 2016
Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz Rio de Janeiro - RJ - Brazil
E-mail: cadernos@ensp.fiocruz.br